Drug management of autosomal dominant polycystic kidney disease.Published in:Australian Prescriber, 2022, v. 45, n. 5, p. 167, doi. 10.18773/austprescr.2022.052By:Theivendran, Thiveya;Ramachandran, Alister;Rangan, GopiPublication type:Article
Role of extracellular ATP and P2 receptor signaling in regulating renal cyst growth and interstitial inflammation in polycystic kidney disease.Published in:Frontiers in Physiology, 2013, v. 3, p. 1, doi. 10.3389/fphys.2013.00218By:Rangan, GopiPublication type:Article
Treatments to slow progression of autosomal dominant polycystic kidney disease: systematic review and meta-analysis of randomized trials.Published in:Nephrology, 2014, v. 19, n. 4, p. 217, doi. 10.1111/nep.12211By:Myint, Thida M;Rangan, Gopi K;Webster, Angela CPublication type:Article